RecruitingNot ApplicableNCT06529185

Effect of Breather in COPD Patients with Intermittent Claudication

Effect of Breather on Ventilatory and Vascular Function in Chronic Obstructive Pulmonary Disease Patients with Intermittent Claudication.


Sponsor

Cairo University

Enrollment

60 participants

Start Date

Jul 30, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study To show the effect of breather on ventilatory and vascular function in COPD patient with intermittent claudication.


Eligibility

Sex: MALEMin Age: 50 YearsMax Age: 60 Years

Inclusion Criteria6

  • sixty male patients with diagnosed with grade I and grade II COPD their ages ranged between 55-60years
  • All patients will be clinically and medically stable when attending the study.
  • Body mass index (BMI) is 18.5 to 24.9 kg/m2.
  • History of unilateral exertional leg pain,
  • Ambulation during a graded treadmill test limited by leg pain consistent with intermittent claudication (stage II of the fontaine classification of pad),
  • And an ankle-brachial index (ABI) of 0.90 or lower at rest or 0.73 or lower after exercise.

Exclusion Criteria11

  • cardiovascular insufficiency,
  • Recent myocardial infarction,
  • heart failure,
  • arrhythmia,
  • DVT,
  • Intracranial hypertension,
  • Pneumonia,
  • kidney failure,
  • fractures,
  • uncooperative patients,
  • cognitive impairment preventing a patient from participation in exercises.

Interventions

DEVICEThe BREATHER

The BREATHER is Light/Medium resistance inspiratory muscle trainer which has significance role in increasing inspiratory muscle strength and endurance which could result in a decreased sensation of dyspnea

DRUGpharmacological treatment

patient will receive the usually pharmacological treatment.


Locations(1)

Faculty of Physical Therapy

Dokki, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06529185


Related Trials